Alan Ezekowitz

Insider Reports History

Entity
Individual
Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Ran Xiao, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Ezekowitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Septerna, Inc. Director Common Stock 117K $813K $6.93 Mar 7, 2025 Direct
Organon & Co. Director Phantom Stock 36.5K $756K $20.75 Jun 7, 2024 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 30K Jun 17, 2024 Direct

Insider Reports Filed by Alan Ezekowitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SEPN Septerna, Inc. Mar 7, 2025 1 $92.3K 4 Mar 10, 2025 Director
SEPN Septerna, Inc. Mar 4, 2025 3 $516K 4 Mar 6, 2025 Director
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Director
OGN Organon & Co. Jun 7, 2024 1 $200K 4 Jun 11, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2023 1 $0 4 Jun 29, 2023 Director
OGN Organon & Co. Jun 9, 2023 1 $200K 4 Jun 13, 2023 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2022 2 $0 4 Jun 29, 2022 Director
OGN Organon & Co. Jun 10, 2022 1 $200K 4 Jun 14, 2022 Director
FULC Fulcrum Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
OGN Organon & Co. Jun 4, 2021 1 $316K 4 Jun 8, 2021 Director
OGN Organon & Co. Jun 2, 2021 0 $0 3 Jun 2, 2021 Director